Skip to main content

Table 2 Comparisons of log-transformed leptin and log-transformed A-FABP levels in adult onset MS patients to healthy controls

From: Increased leptin and A-FABP levels in relapsing and progressive forms of MS

   Adjusted for batch and age Adjusted for batch, age and BMI
Leptin Healthy controls Reference Reference
Relapsing remitting MS 0.66 +/− 0.28 (0.020) 0.43 +/− 0.23 (0.067)
Secondary progressive MS 1.01 +/− 0.33 (0.003) 0.59 +/− 0.28 (0.041)
Primary progressive MS 0.16 +/− 0.34 (0.63) −0.09 +/− 0.28 (0.74)
Four group comparison p-value 0.008 0.054
A-FABP Healthy controls Reference Reference
Relapsing remitting MS 0.07 +/− 0.17 (0.69) 0.02 +/− 0.17 (0.90)
Secondary progressive MS 0.49 +/− 0.21 (0.021) 0.34 +/− 0.21 (0.098)
Primary progressive MS 0.26 +/− 0.18 (0.16) 0.15 +/− 0.18 (0.41)
  Four group comparison p-value 0.117 0.403
  1. Legend: The estimated difference +/− standard error (p-value) between each group and the healthy controls are presented. MS = multiple sclerosis, A-FABP = adipocyte fatty acid binding protein, BMI = body mass index.